Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “HIV”

CAR-T Cells for HIV InfectionRecruiting
NCT04648046Phase 1, Phase 2Updated Apr 9, 2026
Sponsor: Steven Deeks
HIV Infections
United States
Low Dose Naltrexone for Pain in Patients With HIVRecruiting
NCT05537935Phase 4Updated Apr 9, 2026
Sponsor: Emory University
Human Immunodeficiency Virus · Chronic Neuropathic Pain
United States
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant FamiliesRecruiting
NCT06627764NAUpdated Apr 9, 2026
Sponsor: Duke University
Substance Abuse · Intimate Partner Violence (IPV) · HIV Infections · Depression
United States
Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, SwitzerlandNot Yet Recruiting
NCT07516912N/AUpdated Apr 8, 2026
Sponsor: University of Zurich
HIV (Human Immunodeficiency Virus) · Chlamydia · Gonorrhea · Syphilis
Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in ThailandRecruiting
NCT07509853NAUpdated Apr 8, 2026
Sponsor: Institute of HIV Research and Innovation Foundation, Thailand
HIV Prevention · Substance Use · Mental Health · Sexually Transmitted Infections (STIs)
Thailand
Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)Completed
NCT00113282Phase 2Updated Apr 8, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections
France
Estradiol Therapy In Transgender Women to Research Interactions With HIV TherapyTerminated
NCT06005610Phase 2Updated Apr 8, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
HIV I Infection
United States, Mexico, Peru, Thailand
Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy VolunteersCompleted
NCT00490074Phase 1, Phase 2Updated Apr 8, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV Infections
France, Switzerland
Evaluation of a New Strategy to Approach the Transgender Sex Worker Populations and Their Clients for Access to a Preventive Sexual Health System Through the ORTIF Digital Teleconsultation SolutionNot Yet Recruiting
NCT07516691N/AUpdated Apr 8, 2026
Sponsor: Assistance Publique - Hôpitaux de Paris
HIV
France
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support InterventionRecruiting
NCT05723653NAUpdated Apr 8, 2026
Sponsor: University of Chicago
HIV Seropositivity
United States
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)Completed
NCT00115609Phase 3Updated Apr 8, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections · Tuberculosis
France
Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation Hybrid StudyRecruiting
NCT06880224NAUpdated Apr 8, 2026
Sponsor: Northwestern University
Adolescent HIV Infection
Nigeria
Persuasive Health Communication Intervention for HIV/HCVRecruiting
NCT05968573NAUpdated Apr 8, 2026
Sponsor: University of South Florida
Human Immunodeficiency Virus (HIV) · Hepatitis C (HCV)
United States
Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing OptionsTerminated
NCT02834572NAUpdated Apr 8, 2026
Sponsor: New York Blood Center
HIV Testing
United States
National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) InfectionCompleted
NCT02987530Phase 3Updated Apr 7, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV-1 Infection
France
Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136Completed
NCT00421551Phase 3Updated Apr 7, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections
France
Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase InhibitorsCompleted
NCT02738502Phase 2Updated Apr 7, 2026
Sponsor: ANRS, Emerging Infectious Diseases
Maternal-fetal Infection Transmission
France
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1Terminated
NCT04480554Phase 2Updated Apr 7, 2026
Sponsor: University of Pennsylvania
Opioid-use Disorder · HIV-1-infection · Immune Activation · Inflammation
United States, Vietnam
Cannabis, HIV and Mental Processing SystemsCompleted
NCT05430490N/AUpdated Apr 7, 2026
Sponsor: Washington University School of Medicine
HIV Infections · Cannabis
United States
Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)Completed
NCT00670839Phase 3Updated Apr 7, 2026
Sponsor: ANRS, Emerging Infectious Diseases
Hepatitis B · HIV Infection
France
Clinical Trial to Evaluate the Immunogenicity and Safety of an Adjuvanted A(H1N1)v Influenza Vaccine and a Non-adjuvanted A(H1N1)v Influenza Vaccine in HIV-infected Patients (ANRS 151 Hifluvac)Completed
NCT01008813Phase 2Updated Apr 7, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections
France
Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 PrimevaCompleted
NCT00424814Phase 2, Phase 3Updated Apr 7, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV Infections
France
Early and Intermittent Antiretroviral Therapy in Naive HIV Infected AdultsCompleted
NCT00820118Phase 2Updated Apr 7, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV Infections
France
Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)Completed
NCT00302822Phase 3Updated Apr 7, 2026
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
HIV Infections · AIDS
France
the ANRS CO21 " Extreme " Cohort (CODEX)Recruiting
NCT01520844NAUpdated Apr 7, 2026
Sponsor: ANRS, Emerging Infectious Diseases
HIV Infection
France

Previous page Next page